Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.210
-0.070 (-5.47%)
At close: Apr 9, 2026, 4:00 PM EDT
1.240
+0.030 (2.48%)
After-hours: Apr 9, 2026, 7:50 PM EDT
Dermata Therapeutics Employees
Dermata Therapeutics had 8 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
8
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$944,820
Market Cap
4.87M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 8 | 0 | - |
| Dec 31, 2023 | 8 | 0 | - |
| Dec 31, 2022 | 8 | 0 | - |
| Dec 31, 2021 | 8 | 1 | 14.29% |
| Mar 31, 2021 | 7 | - | - |
| Dec 31, 2020 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| CollPlant Biotechnologies | 57 |
| Jaguar Health | 49 |
| KALA BIO | 38 |
| Aptevo Therapeutics | 37 |
| BiomX | 20 |
| Ensysce Biosciences | 8 |
| Artelo Biosciences | 7 |
| Mustang Bio | 4 |
DRMA News
- 7 days ago - Dermata Receives Notice of Acceptance of Australian Patent Application for Topical Application of Dermal Fillers with its Bioneedle Delivery System - Accesswire
- 14 days ago - Dermata Therapeutics Provides Corporate Update and Reports Financial Results for the Year Ended 2025 - Accesswire
- 20 days ago - Dermata Shares Rise After USPTO Issues Patent Notice Of Allowance - Benzinga
- 4 weeks ago - Dermata Announces Appointment of Kyra Peckaitis as Vice President, Marketing - Accesswire
- 5 weeks ago - Dermata Opens a New Chapter with the Release of Tome Skincare - Accesswire
- 2 months ago - Dermata Receives Notice of Grant of Patent for Next-Generation Acne Treatment by Australian Patent Office - Accesswire
- 3 months ago - Dermata Therapeutics Announces Closing of up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire
- 3 months ago - Dermata Therapeutics Announces up to $12.4 Million Private Placement Priced At-The-Market Under Nasdaq Rules - Accesswire